Pricing Log in Create free account

BillionToOne, Inc. (BLLN) vs Sotera Health Company (SHC)

BillionToOne, Inc. and Sotera Health Company are both Diagnostics & Research companies. BillionToOne, Inc. is the larger, with a market value of $5.3B against $4.5B — 1.2× the size. Sotera Health Company trades at the lower P/E: 26.3× against 88.7×. BillionToOne, Inc. grew revenue faster over the last twelve months: 76.5% against 6.90%. Sotera Health Company has the higher net margin (14.1% vs 11.2%) and the higher return on invested capital (9.80% vs 0.00%). Across the 20 metrics below, Sotera Health Company leads on 13 and BillionToOne, Inc. on 7.

Valuation

Metric BLLN SHC Diagnostics & Research median
P/E 88.69 26.27 34.52
P/S 12.11 3.69 4.24
P/B 9.86 6.19 3.42
Price to free cash flow 156.11 33.51 33.51
EV/EBITDA 86.69 11.86 23.44
EV/Sales 11.03 5.18 5.18
Earnings yield 1.13% 3.81% (1.50%)
Free cash flow yield 0.64% 2.98% 0.00%

Profitability

Metric BLLN SHC Diagnostics & Research median
Gross margin 71.41% 54.62% 48.32%
Operating margin 10.23% 32.66% (5.68%)
Net margin 11.23% 14.11% (4.10%)
Free cash flow margin 7.76% 11.01% 0.00%
Return on equity 0.00% 27.03% 0.00%
Return on assets 9.02% 5.28% (6.05%)
Return on invested capital 0.00% 9.80% 0.00%

Growth

Metric BLLN SHC Diagnostics & Research median
Revenue growth (TTM) 76.53% 6.90% 8.99%
EPS growth (last fiscal year) 103.40% 68.75% 20.36%
Revenue growth, 5-year CAGR — 7.30% 7.30%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BLLN SHC Diagnostics & Research median
Debt to equity 0.00 3.06 0.01
Current ratio 11.25 3.13 2.27
Net debt to EBITDA (15.70) 3.74 0.68

Dividend

Metric BLLN SHC Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric BLLN SHC Diagnostics & Research median
Market cap 5.30b 4.53b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack